Table 2 Time to onset of Deutetrabenazine-associated adverse events and Weibull distribution analysis
Drug | Time to onset (days) | Weibull distribution | |||
|---|---|---|---|---|---|
Case reports | Median (IQR) | Scale parameter: α (95% CI) | Shape parameter: β (95%CI) | Type | |
Deutetrabenazine | 372 | 40.5 (11–200) | 106.80 (87.20–126.41) | 0.59 (0.54–0.63) | Early failure |